PURE Bioscience Raises $1.27 Million from Warrant Exercise

May 24, 2016 OTC Disclosure & News Service, PURE PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that the Company raised $1.27 million from the recent exercise by all of the holders of the 2,820,670 warrants expiring May 23, 2016. Use of proceeds will include the commercialization of FDA approved PURE Control® antimicrobial as a processing aid for fresh produce and for raw poultry. PURE Control is a superior, broad spectrum, The post PURE Bioscience Raises $1.27 Million from Warrant Exercise appeared first on Public Wire.
http://bit.ly/1TUYmIE

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: